10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended February 28, 2023

OR

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to

Commission File Number: 1-35447

TRILOGY METALS INC.

(Exact Name of Registrant as Specified in Its Charter)

British Columbia	98-1006991
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)
Suite 1150, 609 Granville Street Vancouver, British Columbia Canada	V7Y 1G5
(Address of Principal Executive Offices)	(Zip Code)

(604) 638-8088

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Shares	TMQ	NYSE American Toronto Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ◻ Accelerated filer ◻ Non-accelerated filer ☒ Smaller reporting company☒ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 5, 2023, the registrant had 148,956,662 Common Shares, no par value, outstanding.

Trilogy Metals Inc.

Table of Contents

		Page
PART I - FINANCIAL INFORMATION		3
Item 1.	Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	22
Item 4.	Controls and Procedures	22
PART II - OTHER INFORMATION		23
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23
Item 3.	Defaults Upon Senior Securities	23
Item 4.	Mine Safety Disclosures	23
Item 5.	Other Information	23
Item 6.	Exhibits	23

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

Trilogy Metals Inc.

Interim Consolidated Balance Sheets

(unaudited)

		in thousands of US dollars
	February 28, 2023		November 30, 2022
	$		$
Assets
Current assets
Cash	1,682		2,573
Accounts receivable	26		17
Deposits and prepaid amounts	163		320
Total current assets	1,871		2,910
Investment in Ambler Metals LLC (note 3)	141,380		142,754
Fixed assets	10		12
Right of use asset (note 5 (a))	276		319
Total assets	143,537		145,995
Liabilities
Current liabilities
Accounts payable and accrued liabilities (note 4)	670		345
Current portion of lease liability	176		189
Total current liabilities	846		534
Long-term portion of lease liability (note 5 (b))	—		33
Total liabilities	846		567
Shareholders’ equity
Share capital (note 6) – unlimited common shares authorized, no par value Issued – 148,722,699 (2022 – 146,225,035)	183,831		182,178
Contributed surplus	121		122
Contributed surplus – options (note 6(a))	27,872		27,352
Contributed surplus – units (note 6(b))	2,801		2,638
Deficit	(71,934)		(66,862)
Total shareholders' equity	142,691		145,428
Total liabilities and shareholders' equity	143,537		145,995

Commitments (note 8)

(See accompanying notes to the interim consolidated financial statements)

/s/ Tony Giardini, President, CEO and Director	/s/ Kalidas Madhavpeddi, Director
Approved on behalf of the Board of Directors

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 3

`

Trilogy Metals Inc.

Interim Consolidated Statements of Loss

and Comprehensive Loss

(unaudited)

in thousands of US dollars, except share and per share amounts
	For the three months ended
		February 28, 2023	February 28, 2022
		$	$
Expenses
Amortization		2	6
Exploration expenses		1	29
Foreign exchange (gain) loss		(4)	3
General and administrative		408	397
Investor relations		30	99
Professional fees		570	245
Salaries		237	414
Salaries and directors expense – stock-based compensation		2,362	1,922
Total expenses		3,606	3,115
Other items
Interest and other income		(19)	(2)
Share of loss on equity investment (note 3(b))		1,485	1,910
Loss and comprehensive loss for the period		(5,072)	(5,023)
Basic loss per common share		(0.03)	(0.03)
Diluted loss per common share		(0.03)	(0.03)
Basic weighted average number of common shares outstanding		147,768,741	145,286,456
Diluted weighted average number of common shares outstanding		147,768,741	145,286,456

(See accompanying notes to the interim consolidated financial statements)

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 4

Trilogy Metals Inc.

Interim Consolidated Statements of Changes in Shareholders’ Equity

(unaudited)

in thousands of US dollars, except share amounts

				Contributed	Contributed		Total
			Contributed	surplus –	surplus –		shareholders’
	Number of shares	Share capital	surplus	options	units	Deficit	equity
	outstanding	$	$	$	$	$	$
Balance – November 30, 2021	145,009,811	180,820	122	25,990	1,712	(42,605)	166,039
Exercise of options	31,674	50	—	(32)	—	—	18
Restricted Share Units	391,332	650	—	—	(650)	—	—
Joint venture contribution	31,469	51	—	—	—	—	51
Stock-based compensation	—	—	—	864	1,001	—	1,865
Loss for the period	—	—	—	—	—	(5,023)	(5,023)
Balance – February 28, 2022	145,464,286	181,571	122	26,822	2,063	(47,628)	162,950
Balance – November 30, 2022	146,225,035	182,178	122	27,352	2,638	(66,862)	145,428
Exercise of options	—	—	—	—	—	—	—
Restricted Share Units	2,346,366	1,538	(1)	—	(1,537)	—	—
Joint venture contribution	143,505	111	—	—	—	—	111
Services settled by common shares	7,793	4	—	—	—	—	4
Stock-based compensation	—	—	—	520	1,700	—	2,220
Loss for the period	—	—	—	—	—	(5,072)	(5,072)
Balance – February 28, 2023	148,722,699	183,831	121	27,872	2,801	(71,934)	142,691

(See accompanying notes to the interim consolidated financial statements)

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 5

Trilogy Metals Inc.

Interim Consolidated Statements of Cash Flows

(unaudited)

	in thousands of US dollars
	For the three months ended
		February 28, 2023		February 28, 2022
			$		$
Cash flows used in operating activities
Loss for the period			(5,072)		(5,023)
Adjustments to reconcile net loss to cash flows in operating activities
Amortization			2		6
Professional fees settled by common shares			21		—
Office lease accounting			(2)		(4)
Loss on equity investment in Ambler Metals LLC (note 4(b))			1,485		1,910
Unrealized foreign exchange loss			4		2
Stock-based compensation			2,362		1,865
Net change in non-cash working capital
Decrease (increase) in accounts receivable			(9)		2
Decrease in deposits and prepaid amounts			157		43
(Decrease) increase in accounts payable and accrued liabilities			167		(281)
Total cash flows used in operating activities			(885)		(1,480)
Cash flows from financing activities
Proceeds from exercise of options			—		18
Total cash flows from financing activities			—		18
Cash flows from investing activities
Total cash flows from investing activities			—		—
Decrease in cash			(885)		(1,462)
Effect of exchange rate on cash			(6)		1
Cash – beginning of the period			2,573		6,308
Cash – end of the period			1,682		4,847

(See accompanying notes to the interim consolidated financial statements)

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 6

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

1)    Nature of operations and Going Concern

Trilogy Metals Inc. (“Trilogy” or the “Company”) was incorporated in British Columbia under the Business Corporations Act (BC) on April 27, 2011. The Company is engaged in the exploration and development of mineral properties, through our equity investee (see note 3), with a focus on the Upper Kobuk Mineral Projects (“UKMP”), including the Arctic and Bornite Projects located in Northwest Alaska in the United States of America (“US”). The Company also conducts early-stage exploration through a wholly owned subsidiary, 995 Exploration Inc.  

These interim consolidated financial statements have been prepared on a going concern basis which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.  At February 28, 2023, we had a working capital surplus of $1.0 million (2022 - $2.4 million) and an accumulated deficit of $71.9 million (2022 - $66.9 million). The Company has no recurring source of cash inflows at its current stage.  The Company’s cash outflow from operations was $0.9 million for the first quarter ended February 28, 2023.  The Company intends to finance its future requirements through a combination of debt and/or equity issuance.  There is no assurance that the Company will be able to obtain such financings or obtain them on favourable terms.  These uncertainties raise substantial doubt about the Company’s ability to continue as a going concern.  These interim consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.  Such adjustments could be material.

2)    Summary of significant accounting policies

Basis of presentation

These interim consolidated financial statements have been prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Trilogy and its wholly owned subsidiaries, NovaCopper US Inc. (dba “Trilogy Metals US”) and 995 Exploration Inc. All intercompany transactions are eliminated on consolidation. For variable interest entities (“VIEs”) where Trilogy is not the primary beneficiary, we use the equity method of accounting.

All figures are in United States dollars unless otherwise noted. References to CDN$ refer to amounts in Canadian dollars.

These interim consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s financial position as of February 28, 2023 and our results of operations and cash flows for the three-month period ended February 28, 2023 and February 28, 2022. The results of operations for the three-month period ended February 28, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending November 30, 2023.

As these interim consolidated financial statements do not contain all of the disclosures required by U.S. GAAP for annual financial statements, these interim consolidated financial statements should be read in conjunction with the annual financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2022, filed with the U.S. Securities and Exchange Commission (“SEC”) and Canadian securities regulatory authorities on February 14, 2023.

These interim consolidated financial statements were approved by the Company’s Audit Committee on behalf of the Board of Directors for issue on April 4, 2023.

Use of estimates and measurement uncertainties

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions of future events that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of expenditures during the period. Significant

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 7

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

judgments include the assessment of potential indicators of equity method investments where key judgement is the delay on the Ambler Access Project is temporary and the delay was considered when assessing indicators of impairment. Significant estimates include the measurement of income taxes, and the valuation of stock-based compensation. Actual results could differ materially from those reported.

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable. Significant judgments are made in assessing the possibility of impairment. Factors that may be indicative of an impairment include a loss in the value of an investment that is not temporary. Management considers several factors in considering if an indicator of impairment has occurred, including but not limited to, sustained losses by the investment, the absence of the ability to recover the carrying amount of the investment, significant changes in the legal, business or regulatory environment, significant adverse changes impacting the investee and internal reporting indicating the economic performance of an investment is, or will be, worse than expected. 

These factors are subjective and require consideration at each period end. If an indicator of impairment is determined to exist, the fair value of the impaired investment is determined based on the valuation of cohort companies with similar projects or upon the present value of expected future cash flows using discount rates and other assumptions believed to be consistent with those used by principal market participants and observed market earnings multiples of comparable companies. 

Management calculates the estimated undiscounted future net cash flows relating to the asset or asset group using estimated future prices, proven and probable reserves and other mineral resources, and operating, capital and reclamation costs. When the carrying value of an asset exceeds the related undiscounted cash flows, the asset is written down to its estimated fair value, which is usually determined using discounted future cash flows. Management’s estimates of mineral prices, mineral resources, foreign exchange rates, production levels operating, capital and reclamation costs are subject to risk and uncertainties that may affect the determination of the recoverability of the long-lived asset. It is possible that material changes could occur that may adversely affect management’s estimates.

3)    Investment in Ambler Metals LLC

(a) Formation of Ambler Metals LLC

On February 11, 2020, the Company completed the formation of a 50/50 joint venture named Ambler Metals LLC (“Ambler Metals”) with South32 Limited (“South32”). As part of the formation of the joint venture, Trilogy contributed all its assets associated with the UKMP, including the Arctic and Bornite Projects, while South32 contributed cash of $145 million, resulting in each party’s subsidiaries directly owning a 50% interest in Ambler Metals.

Ambler Metals is an independently operated company jointly controlled by Trilogy and South32 through a four-member board, of which two members are appointed by Trilogy based on its 50% equity interest. All significant decisions related to the UKMP require the approval of both companies. We determined that Ambler Metals is a VIE because it is expected to need additional funding from its owners for its significant activities. However, we concluded that we are not the primary beneficiary of Ambler Metals as the power to direct its activities, through its board, is shared under the Ambler Metals LLC limited liability company agreement. As we have significant influence over Ambler Metals through our representation on its board, we use the equity method of accounting for our investment in Ambler Metals. Our investment in Ambler Metals was initially measured at its fair value of $176 million upon recognition. Our maximum exposure to loss in this entity is limited to the carrying amount of our investment in Ambler Metals, which, as at February 28, 2023, totaled $141.4 million.

(b) Carrying value of equity method investment

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 8

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

Trilogy recognized, based on its 50% ownership interest in Ambler Metals, an equity loss equivalent to its pro rata share of Ambler Metals’ comprehensive loss of $3.0 million for the three-month period ending February 28, 2023 (2022 - $3.8 million).  During the three-month period ending February 28, 2023, Trilogy made a $111,000 equity contribution to Ambler Metals through the issuance of 143,505 common shares of the Company as part of the long-term incentive compensation for Ambler Metals executives. Likewise, South32 made an equivalent equity contribution to Ambler Metals for $111,000 in cash for their 50% share. The carrying value of Trilogy’s 50% investment in Ambler Metals as at February 28, 2023 is summarized on the following table.

	in thousands of dollars
	$
November 30, 2022, Investment in Ambler Metals	142,754
Joint venture equity contribution	111
Share of loss on equity investment for the three month period ending February 28, 2023	(1,485)
February 28, 2023, Investment in Ambler Metals	141,380

(c) The following table summarizes Ambler Metals’ Balance Sheet as at February 28, 2023.

	in thousands of dollars
	February 28, 2023	November 30, 2022
	$	$
Total assets	109,541	114,049
Cash	76,476	80,755
Mineral properties	30,899	30,899
Total liabilities	(2,574)	(4,335)
Accounts payable and accrued liabilities	(1,962)	(3,664)
Members' equity (total assets less total liabilities)	106,967	109,714

Members’ cash is held at one bank, the majority of cash is uninsured as at February 28, 2023.

(d) The following table summarizes Ambler Metals' loss for the three-month period ending February 28, 2023.

	in thousands of dollars
		For the three months ended
		February 28, 2023	February 28, 2022
		$	$
Depreciation		37	23
Corporate salaries and wages		444	474
General and administrative		133	232
Mineral property expense		2,285	3,040
Professional fees		159	297
Foreign exchange (gain)/loss		—	2
Interest income		(89)	(248)
Comprehensive loss		2,969	3,820

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 9

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

4)    Accounts payable and accrued liabilities

		in thousands of dollars
	February 28, 2023	November 30, 2022
	$	$
Trade accounts payable	251	188
Accrued liabilities	146	36
Accrued salaries and vacation	273	121
Accounts payable and accrued liabilities	670	345

Included in accrued salaries and vacation approximately $155,000 was settled, subsequent to the end of the first quarter, on March 1, 2023 through the issuance of common shares of the Company.

5)    Leases

(a) Right-of-use asset

	in thousands of dollars
	$
Balance as at November 30, 2022	319
Net amortization	(43)
Balance as at February 28, 2023	276

(b) Lease liabilities

The Company’s lease arrangements primarily consist of an operating lease for our office space ending in June 2024. There are no extension options.

Total lease expense recorded within general and administrative expenses was comprised of the following components:

	in thousands of dollars
	Three months ended	Three months ended
	February 28, 2023	February 28, 2022
	$	$
Operating lease costs	47	47
Variable lease costs	36	35
Total lease expense	83	82

Variable lease costs consist primarily of the Company’s portion of operating costs associated with the office space lease as the Company elected to apply the practical expedient not to separate lease and non-lease components.

As of February 28, 2023, the weighted-average remaining lease term is 1.2 years and the weighted-average discount rate is 8%. Significant judgment was used in the determination of the incremental borrowing rate which included estimating the Company’s credit rating.

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 10

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

Supplemental cash and non-cash information relating to our leases during the three-month period ending February 28, 2023 are as follows:

● Cash paid for amounts included in the measurement of lease liabilities was $49,310.

Future minimum payments relating to the lease recognized in our balance sheet as of February 28, 2023 are as follows:

	in thousands of dollars
	February 28, 2023
Fiscal year	$
2023	149
2024	33
2025	—
Total undiscounted lease payments	182
Effect of discounting	(6)
Present value of lease payments recognized as lease liability	176

6)    Share capital

Authorized:

unlimited common shares, no par value

	in thousands of dollars, except share amounts
	Number of shares	Ascribed value
		$
November 30, 2022	146,225,035	182,178
Restricted Share Units	2,346,366	1,538
Services settled by common shares	7,793	4
Joint venture equity contribution (note 4(b))	143,505	111
February 28, 2023, issued and outstanding	148,722,699	183,831

On April 30, 2012, under the NovaGold Arrangement, Trilogy committed to issue common shares to satisfy holders of NovaGold deferred share units (“NovaGold DSUs”), once vested, on record as of the close of business April 27, 2012. When vested, Trilogy committed to deliver one common share to the holder for every six shares of NovaGold the holder is entitled to receive, rounded down to the nearest whole number. As of February 28, 2023, a total of 9,293 NovaGold DSUs remain outstanding representing a right to receive 1,549 Common Shares in Trilogy, which will settle upon certain directors retiring from NovaGold’s board.

(a) Stock options

During the three-month period ended February 28, 2023, the Company granted 3,230,000 stock options (2022 - 1,734,500 stock options) at an exercise price of CDN$0.78 (2022 - CDN$2.21) to employees, consultants and directors exercisable for a period of five years with various vesting terms from immediate vesting to vesting over a two-year period. The fair value attributable to options granted in the period was CDN$0.37 (2022 - CDN$0.90).

For the three-month period ended February 28, 2023, Trilogy recognized a stock-based compensation charge of $0.5 million (2022 - $0.86 million) for options granted to directors, employees and service providers, net of estimated forfeitures.

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 11

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

The fair value of the stock options recognized in the period has been estimated using the Black-Scholes option pricing model.

Assumptions used in the pricing model for the three-month period ended February 28, 2023 are as provided below.

	February 28, 2023
Risk-free interest rates	3.49%
Exercise price	CDN$0.78
Expected life	3 years
Expected volatility	67.7%
Expected dividends	Nil

As of February 28, 2023, there were 2,148,424 non-vested options outstanding with a weighted average exercise price of CDN$1.03; the non-vested stock option expense not yet recognized was $0.47 million. This expense is expected to be recognized over the 22 months.

A summary of the Company’s stock option plan and changes during the three-month period ended February 28, 2023 is as follows:

		February 28, 2023
		Weighted average
		exercise price
	Number of options	CDN$
Balance – beginning of the period	11,225,400	2.49
Granted	3,230,000	0.78
Expired	(870,000)	1.05
Balance – end of the period	13,585,400	2.18

There were no stock options exercised during the first quarter 2023.

The following table summarizes information about the stock options outstanding at February 28, 2023.

	Outstanding			Exercisable		Unvested
			Weighted		Weighted
	Number of	Weighted	average	Number of	average	Number of
	outstanding	average years	exercise price	exercisable	exercise price	unvested
Range of exercise price - CDN	options	to expiry	CDN$	options	CDN$	options
$0.75 to $1.00	3,230,000	4.77	0.78	1,463,328	0.78	1,766,672
$2.00 to $2.50	2,396,250	2.96	2.27	2,014,498	2.28	381,752
$2.51 to $3.00	6,411,650	2.14	2.64	6,411,650	2.64	—
$3.01 to $3.41	1,547,500	1.81	3.03	1,547,500	3.03	—
	13,585,400	2.87	2.18	11,436,976	2.39	2,148,424

The aggregate intrinsic value of vested stock options (the market value less the exercise price) at February 28, 2023 was $0.02 million (2022 - $0.15 million) and the aggregate intrinsic value of exercised options for the three-month period ending February 28, 2023 was $Nil million (2022 - $0.03 million).

(b) Restricted Share Units and Deferred Share Units

The Company has a Restricted Share Unit Plan (“RSU Plan”) to provide long-term incentives to employees and consultants and a Non-Executive Director Deferred Share Unit Plan (“DSU Plan”) to offset cash payments for fees to directors.  Awards under the RSU Plan and DSU Plan have been settled in common shares of the Company with each restricted share unit

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 12

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

(“RSU”) and deferred share unit (“DSU”) entitling the holder to receive one common share of the Company.  All units are accounted for as equity-settled awards.

A summary of the Company’s unit plans and changes during the three-month period ending February 28, 2023 is as follows:

	Number of RSUs	Number of DSUs
Balance – beginning of the period	257,268	1,560,734
Granted	3,699,297	760,519
Vested	(2,345,927)	—
Balance – end of the period	1,610,638	2,321,253

For the three-month period ending February 28, 2023, Trilogy recognized a combined RSU and DSU stock-based compensation charge of $1.1 million (2022 - $1.0 million), net of estimated forfeitures.

7)    Financial instruments

The Company is exposed to a variety of risks arising from financial instruments. These risks and management’s objectives, policies and procedures for managing these risks are disclosed as follows.

The Company’s financial instruments consist of cash, accounts receivable, deposits, and accounts payable and accrued liabilities. The fair value of the Company’s financial instruments approximates their carrying value due to the short-term nature of their maturity. The Company’s financial instruments initially measured at fair value and then held at amortized cost include cash, accounts receivable, deposits, and accounts payable and accrued liabilities.

Financial risk management

The Company’s activities expose it to certain financial risks, including currency risk, credit risk, liquidity risk, interest risk and price risk.

(a) Currency risk

Currency risk is the risk of a fluctuation in financial asset and liability settlement amounts due to a change in foreign exchange rates. The Company operates in the United States and Canada. The Company’s exposure to currency risk at February 28, 2023 is limited to the Canadian dollar balances consisting of cash of approximately CDN$71,000, accounts receivable of approximately CDN$35,000 and accounts payable of approximately CDN$320,000. Based on a 10% change in the US-Canadian exchange rate, assuming all other variables remain constant, the Company’s net loss would change by approximately $35,000.

(b) Credit risk

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company holds cash with a Canadian chartered financial institution of which the majority is uninsured as at February 28, 2023. The Company’s only significant exposure to credit risk is equal to the balance of cash as recorded in the financial statements.

(c) Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulties raising funds to meet its financial obligations as they fall due. The Company is in the exploration stage and does not have cash inflows from operations; therefore, the Company manages liquidity risk through the management of its capital structure and financial leverage.

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 13

Trilogy Metals Inc.

Notes to the Interim Consolidated Financial Statements

Contractually obligated undiscounted cash flow requirements as at February 28, 2023 are as follows:

	in thousands of dollars
	Total	< 1 Year	1–2 Years	2–5 Years	Thereafter
	$	$	$	$	$
Accounts payable and accrued liabilities	670	670	—	—	—
Office lease	182	182	—	—	—
	852	852	—	—	—

Included in accounts payable and accrued liabilities approximately $155,000 is for accrued salaries that were settled, subsequent to the end of the first quarter, on March 1, 2023 through the issuance of common shares of the Company (note 9).

(d) Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk with respect to interest earned on cash. Based on balances as at February 28, 2023, a 1% change in interest rates would result in a negligible change in net loss, assuming all other variables remain constant.

As we are currently in the exploration phase none of our financial instruments are exposed to commodity price risk; however, our ability to obtain long-term financing and its economic viability could be affected by commodity price volatility.

8)    Commitment

The Company has commitments with respect to an office lease requiring future minimum lease payments as summarized in note 5(b) above.

9) Subsequent event

On March 1, 2023 the Board of Directors and senior management were granted 213,463 RSUs and 162,469 DSUs in settlement of approximately $247,000 of director fees and accrued salaries, all vesting immediately. The grants were in support of an effort to preserve cash and increase share ownership by settling director fees and a portion of senior management salaries in shares of the Company.

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 14

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Trilogy Metals Inc.

Management’s Discussion & Analysis

For the Quarter Ended February 28, 2023

(expressed in US dollars)

Cautionary notes

Forward-looking statements

This Management’s Discussion and Analysis contains “forward-looking information” and “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), and other applicable securities laws. These forward-looking statements may include statements regarding the Company’s work programs and budgets, including statements about

the plans and budget for the 2023 field exploration program; perceived merit of properties, exploration results and budgets, the impact of the BLM’s suspension of permits on the right-of-way with AIDEA relating to the Ambler Road Project; the Company and Ambler Metals’ funding requirements, mineral reserves and resource estimates, work programs, capital expenditures, operating costs, cash flow estimates, production estimates and similar statements relating to the economic viability of a project, timelines, strategic plans, statements regarding Ambler Metals’ plans and expectations relating to its Upper Kobuk Mineral Projects, sufficiency of the $145 million subscription price to fund the UKMP; impact of COVID-19 on the Company’s operations; market prices for precious and base metals; statements regarding the Ambler Access Project (also known as the Ambler Mining District Industrial Access Project); or other statements that are not statements of fact. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Statements concerning mineral resource estimates may also be deemed to constitute “forward-looking statements” to the extent that they involve estimates of the mineralization that will be encountered if the property is developed.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, identified by words or phrases such as “expects”, “is expected”, “anticipates”, “believes”, “plans”, “projects”, “estimates”, “assumes”, “intends”, “strategy”, “goals”, “objectives”, “potential”, “possible” or variations thereof or stating that certain actions, events, conditions or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking statements.

Forward-looking statements are based on the beliefs, expectations and opinions of management on the date the statements are made, as well as on a number of material assumptions, which could prove to be significantly incorrect, including about:

● our ability to achieve production at the Upper Kobuk Mineral Projects;

● the accuracy of our mineral resource and reserve estimates;

● the results, costs and timing of future exploration drilling and engineering;

● timing and receipt of approvals, consents and permits under applicable legislation;

● the adequacy of our financial resources;

● the receipt of third party contractual, regulatory and governmental approvals for the exploration, development, construction and production of our properties and any litigation or challenges to such approvals;

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 15

● our expected ability to develop adequate infrastructure and that the cost of doing so will be reasonable;

● continued good relationships with South32, our joint venture partner, as well as local communities and other stakeholders;

● there being no significant disruptions affecting operations, whether relating to labor, supply, power damage to equipment or other matter;

● expected trends and specific assumptions regarding metal prices and currency exchange rates;

● the potential impact of the novel coronavirus (COVID-19); and

● prices for and availability of fuel, electricity, parts and equipment and other key supplies remaining consistent with current levels.

We have also assumed that no significant events will occur outside of our normal course of business. Although we have attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. We believe that the assumptions inherent in the forward-looking statements are reasonable as of the date of this MD&A. However, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to the inherent uncertainty therein.

Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those reflected in the forward-looking statements, including, without limitation:

● risks related to the COVID-19 pandemic;

● risks related to inability to define proven and probable reserves;

● risks related to our ability to finance the development of our mineral properties through external financing, strategic alliances, the sale of property interests or otherwise;

● uncertainty as to whether there will ever be production at the Company’s mineral exploration and development properties;

● risks related to our ability to commence production and generate material revenues or obtain adequate financing for our planned exploration and development activities;

● risks related to lack of infrastructure including but not limited to the risk whether or not the Ambler Mining District Industrial Access Project, or AMDIAP, will receive the requisite permits and, if it does, whether the Alaska Industrial Development and Export Authority will build the AMDIAP;

● risks related to the suspension by the BLM of the right-of-way permits with AIDEA relating to the AMDIAP to permit the Department of the Interior to carry out additional work on the environmental impact statement, and associated delays relating to such suspension;

● risks related to inclement weather which may delay or hinder exploration activities at our mineral properties;

● risks related to our dependence on a third party for the development of our projects;

● none of the Company’s mineral properties are in production or are under development;

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 16

● commodity price fluctuations;

● uncertainty related to title to our mineral properties;

● our history of losses and expectation of future losses;

● risks related to increases in demand for equipment, skilled labor and services needed for exploration and development of mineral properties, and related cost increases;

● risks related to increases in costs of fuel and other required supplies and concerns relating to supply chain and the ability to obtain needed supplies at a reasonable cost, or at all;

● risks related to global economic instability, including global supply chain issues, inflation and fuel and energy costs may affect the Company’s business;

● uncertainties relating to the assumptions underlying our resource estimates, such as metal pricing, metallurgy, mineability, marketability and operating and capital costs;

● uncertainty related to inferred mineral resources;

● mining and development risks, including risks related to infrastructure, accidents, equipment breakdowns, labor disputes or other unanticipated difficulties with or interruptions in development, construction or production;

● risks and uncertainties relating to the interpretation of drill results, the geology, grade and continuity of our mineral deposits;

● risks related to governmental regulation and permits, including environmental regulation, including the risk that more stringent requirements or standards may be adopted or applied due to circumstances unrelated to the Company and outside of our control;

● the risk that permits and governmental approvals necessary to develop and operate mines at our mineral properties will not be available on a timely basis or at all;

● risks related to the need for reclamation activities on our properties and uncertainty of cost estimates related thereto;

● risks related to the acquisition and integration of operations or projects;

● our need to attract and retain qualified management and technical personnel;

● risks related to conflicts of interests of some of our directors and officers;

● risks related to potential future litigation;

● risks related to market events and general economic conditions;

● risks related to future sales or issuances of equity securities decreasing the value of existing Trilogy common shares, diluting voting power and reducing future earnings per share;

● risks related to the voting power of our major shareholders and the impact that a sale by such shareholders may have on our share price;

● uncertainty as to the volatility in the price of the Company’s common shares;

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 17

● the Company’s expectation of not paying cash dividends;

● adverse federal income tax consequences for U.S. shareholders should the Company be a passive foreign investment company;

● risks related to global climate change;

● risks related to adverse publicity from non-governmental organizations;

● uncertainty as to our ability to maintain the adequacy of internal control over financial reporting as per the requirements of Section 404 of the Sarbanes-Oxley Act; and

● increased regulatory compliance costs, associated with rules and regulations promulgated by the United States Securities and Exchange Commission, Canadian Securities Administrators, the NYSE American, the Toronto Stock Exchange, and the Financial Accounting Standards Boards, and more specifically, our efforts to comply with the Dodd-Frank Wall Street Reform and Consumer Protection Act.

This list is not exhaustive of the factors that may affect any of the Company’s forward-looking statements. Forward-looking statements are statements about the future and are inherently uncertain, and actual achievements of the Company or other future events or conditions may differ materially from those reflected in the forward-looking statements due to a variety of risks, uncertainties and other factors, including, without limitation, those referred to in Trilogy’s Form 10-K dated February 14, 2023, filed with the Canadian securities regulatory authorities and the SEC, and other information released by Trilogy and filed with the appropriate regulatory agencies.

The Company’s forward-looking statements are based on the beliefs, expectations and opinions of management on the date the statements are made, and the Company does not assume any obligation to update forward-looking statements if circumstances or management’s beliefs, expectations or opinions should change, except as required by law. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.

General

This Management’s Discussion and Analysis (“MD&A”) of Trilogy Metals Inc. (“Trilogy”, “Trilogy Metals”, “the Company” or “we”) is dated April 4, 2023 and provides an analysis of our unaudited interim financial results for the quarter ended February 28, 2023 compared to the quarter ended February 28, 2022.

The following information should be read in conjunction with our February 28, 2023 unaudited interim condensed consolidated financial statements and related notes which were prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”). The MD&A should also be read in conjunction with our audited consolidated financial statements and related notes for the year ended November 30, 2022. A summary of the U.S. GAAP accounting policies is outlined in note 2 of the audited consolidated financial statements. All amounts are in United States dollars unless otherwise stated. References to “Canadian dollars” and “CDN$” are to the currency of Canada and references to “U.S. dollars”, “$” or “US$” are to the currency of the United States.

Richard Gosse, P.Geo., Vice President, Exploration of the Company, is a Qualified Person under National Instrument 43-101 - Standards of Disclosure for Mineral Projects (“NI 43-101”), and has approved the scientific and technical information in this MD&A.

Trilogy’s shares are listed on the Toronto Stock Exchange (“TSX”) and the NYSE American Stock Exchange (“NYSE American”) under the symbol “TMQ”. Additional information related to Trilogy, including our annual report on Form 10-K, is available on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 18

Description of business

We are a base metals exploration company focused on the exploration and development of mineral properties, through our equity investee, in the Ambler mining district located in Alaska, U.S.A. We conduct our operations through a wholly owned subsidiary, NovaCopper US Inc. which is doing business as Trilogy Metals US (“Trilogy Metals US”). Our Upper Kobuk Mineral Projects, (“UKMP” or “UKMP Projects”) were contributed into a 50/50 joint venture named Ambler Metals LLC (“Ambler Metals”) between Trilogy and South32 Limited (“South32”) on February 11, 2020 (see below). The projects contributed to Ambler Metals consist of: i) the Ambler lands which host the Arctic copper-zinc-lead-gold-silver project (the “Arctic Project”); and ii) the Bornite lands being explored under a collaborative long-term agreement with NANA Regional Corporation, Inc. (“NANA”), a regional Alaska Native Corporation, which hosts the Bornite carbonate-hosted copper project (the “Bornite Project”) and related assets. The Company also conducts early-stage exploration through a wholly owned subsidiary, 995 Exploration Inc.

Project activities

The Company announced the second and third set of drilling results from the 2022 field season at the Upper Kobuk Mineral Projects (“UKMP”) on January 25, 2023 and February 27, 2023, respectively.  On April 4, 2023, the Company announced the final set of drilling results from the 2022 field season at the UKMP.

On February 14, 2023, the Company announced an updated feasibility study technical report for the Arctic Project and an updated resource for the Bornite Project, and filed NI 43-101 technical reports for both projects with the Canadian securities regulators.  In addition, the Company announced technical report summaries for both projects prepared in accordance with S-K 1300, which were filed as exhibits with the annual report on Form 10-K.

Ambler Mining District Industrial Access Project (“AMDIAP” or “Ambler Access Project”)  

On November 15, 2022, the United States Bureau of Land Management ("USBLM") submitted a status report announcing the anticipation of publishing a draft Supplemental Environmental Impact Statement (“SEIS”) in the second quarter of calendar 2023 and a final SEIS in the fourth quarter of calendar 2023. On January 17, 2023, the USBLM submitted a status report reaffirming the timing of the draft and final SEIS.

In March 2023, the Board of Ambler Metals approved a budget totaling $12.3 million for the Ambler Access Project, to include funding for 2023 field season work consisting of field studies, permitting and data collection to assist the USBLM in completing the additional work to support the SEIS.

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 19

Summary of results

	in thousands of US dollars, except per share amounts
		For the three months ended
		February 28, 2023		February 28, 2022
Selected expenses		$		$
General and administrative			408		397
Investor relations			30		99
Professional fees			570		245
Salaries			237		414
Salaries and directors expense – stock-based compensation			2,362		1,922
Share of loss on equity investment			1,485		1,910
Comprehensive loss for the period			(5,072)		(5,023)
Basic and diluted loss per common share			(0.03)		(0.03)

For the three-month period ended February 28, 2023, we reported a net loss of $5.1 million compared to a net loss of $5.0 million for the three-month period ended February 28, 2022. The increase in comprehensive loss in the first quarter of 2023 compared to first quarter of 2022 is due to increase in stock based compensation and professional fees and partially offset from the decrease in our share of losses of Ambler Metals, investor relations and salaries.  The decrease in our share of losses of Ambler Metals is mainly due to decrease in mineral property expenses.

Liquidity and capital resources

We expended $0.9 million on operating activities during the three-month period ending February 28, 2023 with the majority of cash spent on corporate salaries, professional fees related to our annual regulatory filings, and annual fees paid to the Toronto Stock Exchange and the NYSE American Exchange with the American and Canadian securities commissions.  

As at February 28, 2023, we had $1.7 million in cash and working capital of $1.0 million. Management continues with cash preservation strategies to reduce cash expenditures where feasible, including but not limited to reductions in marketing and investor conferences and office expenses.  In addition, the Company’s Board of Directors have agreed to take all of their fees in DSUs in an effort to preserve cash.  The Company’s senior management team is also taking a portion of their base salaries in shares of the Company to preserve cash.

All project related costs are funded by the Joint Venture. Amber Metals is well funded to advance the UKMP with $76.5 million in cash and $74.9 million in working capital as at February 28, 2023. There are sufficient funds at the Joint Venture to fund this fiscal year’s budget for the UKMP and the Ambler Access Project. Trilogy does not anticipate having to fund the activities of Ambler Metals until the current cash balance $76.5 million is expended.

Future cash requirements may vary materially from current expectations. The Company will need to raise additional funds in the future to support its operations and administration expenses. Future sources of liquidity are expected to be in the form of an equity financing but may include debt financing, convertible debt, exercise of options, or other means. The continued operations of the Company are dependent on its ability to obtain additional financing or to generate future cash flows.

There is no assurance that the Company will be able to obtain such financings or obtain them on favourable terms.  These uncertainties raise substantial doubt about the Company’s ability to continue as a going concern.

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 20

Off-balance sheet arrangements

We have no material off-balance sheet arrangements.

Outstanding share data

As at April 5, 2023, we had 148,956,662 common shares issued and outstanding. As at April 5, 2023, we had 13,281,400 stock options outstanding with a weighted-average exercise price of CDN$2.17, 2,483,722 Deferred Share Units (“DSUs”), and 1,610,638 Restricted Share Units (“RSUs”) outstanding. As at April 5, 2023 we hold 9,293 NovaGold Resources Inc. (“NovaGold”) DSUs for which the NovaGold director is entitled to receive one common share of Trilogy for every six NovaGold shares to be received upon their retirement from the NovaGold board.  A total of 1,549 common shares will be issued upon redemption of the NovaGold DSUs. Upon the exercise of all the foregoing convertible securities, the Company would be required to issue an aggregate of 17,377,309 common shares.

New accounting pronouncements

There are no new accounting pronouncements affecting the Company.

Critical accounting estimates

The most critical accounting estimates upon which our financial status depends are those requiring estimates of the recoverability of our equity method investment in Ambler Metals, income taxes and valuation of stock‐based compensation.

Impairment of Investment in Ambler Metals LLC

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable. Significant judgments are made in assessing the possibility of impairment. Factors that may be indicative of an impairment include a loss in the value of an investment that is not temporary. Management considers several factors in considering if an indicator of impairment has occurred, including but not limited to, sustained losses by the investment, the absence of the ability to recover the carrying amount of the investment, significant changes in the legal, business or regulatory environment, significant adverse changes impacting the investee including the status of the Ambler Access  Project and internal reporting indicating the economic performance of an investment is, or will be, worse than expected.

These factors are subjective and require consideration at each period end. If an indicator of impairment is determined to exist, the fair value of the impaired investment is determined based on the valuation of cohort companies with similar projects or upon the present value of expected future cash flows using discount rates and other assumptions believed to be consistent with those used by principal market participants and observed market earnings multiples of comparable companies.

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 21

Management calculates the estimated undiscounted future net cash flows relating to the asset or asset group using estimated future prices, proven and probable reserves and other mineral resources, and operating, capital and reclamation costs. When the carrying value of an asset exceeds the related undiscounted cash flows, the asset is written down to its estimated fair value, which is usually determined using discounted future cash flows. Management’s estimates of mineral prices, mineral resources, foreign exchange rates, production levels operating, capital and reclamation costs are subject to risk and uncertainties that may affect the determination of the recoverability of the long-lived asset. It is possible that material changes could occur that may adversely affect management’s estimates.

Income taxes

We must make estimates and judgments in determining the provision for income tax expense, deferred tax assets and liabilities, and liabilities for unrecognized tax benefits including interest and penalties. We are subject to income tax law in the United States and Canada. The evaluation of tax liabilities involving uncertainties in the application of complex tax regulation is based on factors such as changes in facts or circumstances, changes in tax law, new audit activity, and effectively settled issues. The evaluation of an uncertain tax position requires significant judgment, and a change in such recognition would result in an additional charge to the income tax expense and liability.

Stock-based compensation

Compensation expense for options granted to employees, directors and certain service providers is determined based on estimated fair values of the options at the time of grant using the Black-Scholes option pricing model, which takes into account, as of the grant date, the fair market value of the shares, expected volatility, expected life, expected forfeiture rate, expected dividend yield and the risk-free interest rate over the expected life of the option. The use of the Black-Scholes option pricing model requires input estimation of the expected life of the option, volatility, and forfeiture rate which can have a significant impact on the valuation model, and resulting expense recorded.

Additional information

Additional information regarding the Company, including our annual report on Form 10-K, is available on SEDAR at www.sedar.com and EDGAR at www.sec.gov and on our website at www.trilogymetals.com. Information contained on our website is not incorporated by reference.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable.

Item 4. Controls and Procedures

Disclosure controls and procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted by the Company under U.S. and Canadian securities legislation is recorded, processed, summarized and reported within the time periods specified in those rules, including providing reasonable assurance that material information is gathered and reported to senior management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to permit timely decisions regarding public disclosure. Management, including the CEO and CFO, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as defined in Rule 13a-15(e) and 15d-15(e) of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules of Canadian Securities Administration, as of February 28, 2023. Based on this evaluation, the CEO and CFO have concluded that the Company’s disclosure controls and procedures were effective.

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 22

Internal control over financial reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act and National Instrument 52-109 Certification of Disclosure in Issuer’s Annual and Interim filings. Any system of internal control over financial reporting, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

Changes in internal control over financial reporting

There have been no changes in our internal controls over financial reporting during the fiscal quarter ended February 28, 2023 which have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting. We continue to evaluate our internal control over financial reporting on an ongoing basis to identify improvements.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are a party to routine litigation and proceedings that are considered part of the ordinary course of its business. We are not aware of any material current, pending, or threatened litigation.

Item 1A. Risk Factors

Trilogy and its future business, operations and financial condition are subject to various risks and uncertainties due to the nature of its business and the present stage of exploration of its mineral properties. Certain of these risks and uncertainties are under the heading “Risk Factors” under Trilogy’s Form 10-K dated February 14, 2023 (“Form 10-K”) which is available on SEDAR at www.sedar.com and EDGAR at www.sec.gov and on our website at www.trilogymetals.com.  There have been no material changes to the risk factors set forth in Trilogy’s Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

These disclosures are not applicable to us.

Item 5. Other Information

None.

Item 6. Exhibits

Exhibit No.	Description
3.1	Certificate of Incorporation, dated April 27, 2011 (incorporated by reference Exhibit 99.2 to the Registration Statement on Form 40-F as filed on March 1, 2012, File No. 001-35447)

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 23

3.2	Articles of Trilogy Metals Inc., effective April 27, 2011, as altered March 20, 2011 (incorporated by reference to Exhibit 99.3 to Amendment No. 1 to the Registration Statement on Form 40-F as filed on April 19, 2012, File No. 001-35447)
3.3	Notice of Articles and Certificate of Change of Name, dated September 1, 2016 (incorporated by reference to Exhibit 3.1 to the Form 8-K dated September 8, 2016)
31.1	Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)
31.2	Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)
32.1	Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350
32.2	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350
101	Interactive Data Files
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File – the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 24

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: April 5, 2023	TRILOGY METALS INC.
	By:	/s/ Tony Giardini
		Tony Giardini
		President and Chief Executive Officer
	By:	/s/ Elaine M. Sanders
		Elaine M. Sanders
		Vice President and Chief Financial Officer

Trilogy Metals Inc.
For the Quarter Ended February 28, 2023 25

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Tony Giardini, certify that:

1) I have reviewed this Quarterly Report on Form 10-Q of Trilogy Metals Inc.

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:      April 5, 2023

By:	/s/ Tony Giardini
	Tony Giardini
	President and Chief Executive Officer
	(principal executive officer)

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Elaine Sanders, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Trilogy Metals Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:    April 5, 2023

By:	/s/ Elaine Sanders
	Elaine Sanders
	Vice President and Chief Financial Officer
	(principal financial officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Trilogy Metals Inc. (the “Registrant”) for the period ended February 28, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tony Giardini, President and Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	April 5, 2023
By:	/s/ Tony Giardini
	Tony Giardini
	President and Chief Executive Officer
	(principal executive officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Trilogy Metals Inc. (the “Registrant”) for the period ended February 28, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Elaine Sanders, Vice President and Chief Financial Officer of the Registrant, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	April 5, 2023
By:	/s/ Elaine Sanders
	Elaine Sanders
	Vice President and Chief Financial Officer
	(principal financial officer)

XML

Document and Entity Information - shares	3 Months Ended
	Feb. 28, 2023	Apr. 05, 2023
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Feb. 28, 2023
Document Transition Report	false
Entity File Number	1-35447
Entity Registrant Name	TRILOGY METALS INC.
Entity Incorporation, State or Country Code	A1
Entity Tax Identification Number	98-1006991
Entity Address, Address Line One	Suite 1150, 609 Granville Street
Entity Address, City or Town	Vancouver
Entity Address, State or Province	BC
Entity Address, Country	CA
Entity Address, Postal Zip Code	V7Y 1G5
City Area Code	604
Local Phone Number	638-8088
Title of 12(b) Security	Common Shares
Trading Symbol	TMQ
Security Exchange Name	NYSEAMER
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		148,956,662
Current Fiscal Year End Date	--11-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001543418
Amendment Flag	false

XML

Interim Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Feb. 28, 2023	Nov. 30, 2022
Current assets
Cash	$ 1,682	$ 2,573
Accounts receivable	26	17
Deposits and prepaid amounts	163	320
Total current assets	1,871	2,910
Investment in Ambler Metals LLC (note 3)	141,380	142,754
Fixed assets	10	12
Right of use asset (note 5 (a))	276	319
Total assets	143,537	145,995
Current liabilities
Accounts payable and accrued liabilities (note 4)	670	345
Current portion of lease liability	176	189
Total current liabilities	846	534
Long-term portion of lease liability (note 5 (b))		33
Total liabilities	846	567
Shareholders' equity
Share capital (note 6) - unlimited common shares authorized, no par value Issued - 148,722,699 (2022 - 146,225,035)	183,831	182,178
Contributed surplus	121	122
Contributed surplus - options (note 6(a))	27,872	27,352
Contributed surplus - units (note 6(b))	2,801	2,638
Deficit	(71,934)	(66,862)
Total Shareholders' Equity	142,691	145,428
Total Liabilities and Shareholders' Equity	$ 143,537	$ 145,995

XML

Interim Consolidated Balance Sheets (Parenthetical) - $ / shares	3 Months Ended	12 Months Ended
	Feb. 28, 2023	Nov. 30, 2022
Interim Consolidated Balance Sheets (unaudited)
Unlimited common shares authorized	Unlimited	Unlimited
Common Stock, No Par Value	$ 0	$ 0
Common Stock, Shares, Issued	148,722,699	146,225,035

XML

Interim Consolidated Statements of Loss and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Expenses
Amortization	$ 2	$ 6
Exploration expenses	1	29
Foreign exchange (gain)/loss	(4)	3
General and administrative	408	397
Investor relations	30	99
Professional fees	570	245
Salaries	237	414
Salaries and directors expense - stock-based compensation	2,362	1,922
Total expenses	3,606	3,115
Other items
Interest and other income	(19)	(2)
Share of loss on equity investment (note 4(b))	1,485	1,910
Loss and comprehensive loss for the period	$ (5,072)	$ (5,023)
Basic loss per common share	$ (0.03)	$ (0.03)
Diluted loss per common share	$ (0.03)	$ (0.03)
Basic weighted average number of common shares outstanding	147,768,741	145,286,456
Diluted weighted average number of common shares outstanding	147,768,741	145,286,456

XML

Interim Consolidated Statements of Changes in Shareholders' Equity (unaudited) - USD ($) $ in Thousands	Share capital	Contributed surplus.	Contributed surplus - options	Contributed surplus - units.	Deficit	Total
Beginning Balance at Nov. 30, 2021	$ 180,820	$ 122	$ 25,990	$ 1,712	$ (42,605)	$ 166,039
Beginning Balance (Shares) at Nov. 30, 2021	145,009,811
Exercise of options	$ 50		(32)			18
Exercise of options (Shares)	31,674
Restricted Share Units	$ 650			(650)
Restricted Share Units (Shares)	391,332
Joint venture contribution	$ 51					51
Joint venture contribution (Shares)	31,469
Stock-based compensation			864	1,001		1,865
Loss for the period					(5,023)	(5,023)
Ending Balance at Feb. 28, 2022	$ 181,571	122	26,822	2,063	(47,628)	162,950
Ending Balance (Shares) at Feb. 28, 2022	145,464,286
Beginning Balance at Nov. 30, 2022	$ 182,178	122	27,352	2,638	(66,862)	145,428
Beginning Balance (Shares) at Nov. 30, 2022	146,225,035
Restricted Share Units	$ 1,538	(1)		(1,537)
Restricted Share Units (Shares)	2,346,366
Joint venture contribution (Shares)	143,505
Services settled by common shares	$ 4					4
Services settled by common shares (in shares)	7,793
Stock-based compensation			520	1,700		2,220
Loss for the period					(5,072)	(5,072)
Ending Balance at Feb. 28, 2023	$ 183,831	$ 121	$ 27,872	$ 2,801	$ (71,934)	$ 142,691
Ending Balance (Shares) at Feb. 28, 2023	148,722,699

XML

Interim Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Cash flows used in operating activities
Loss for the period	$ (5,072)	$ (5,023)
Adjustments to reconcile net loss to cash flows in operating activities
Amortization	2	6
Professional fees settled by common shares	21
Office lease accounting	(2)	(4)
Loss on equity investment in Ambler Metals LLC (note 4(b))	1,485	1,910
Unrealized foreign exchange loss	4	2
Stock-based compensation	2,362	1,865
Net change in non-cash working capital
Decrease (increase) in accounts receivable	(9)	2
Decrease in deposits and prepaid amounts	157	43
(Decrease) increase in accounts payable and accrued liabilities	167	(281)
Total cash flows used in operating activities	(885)	(1,480)
Cash flows from financing activities
Proceeds from exercise of options		18
Total cash flows from financing activities		18
Decrease in cash	(885)	(1,462)
Effect of exchange rate on cash	(6)	1
Cash - beginning of the period	2,573	6,308
Cash - end of the period	$ 1,682	$ 4,847

XML

Nature of operations and Going Concern

3 Months Ended

Feb. 28, 2023

Nature of operations and Going Concern

Nature of operations and Going Concern

1)    Nature of operations and Going Concern

Trilogy Metals Inc. (“Trilogy” or the “Company”) was incorporated in British Columbia under the Business Corporations Act (BC) on April 27, 2011. The Company is engaged in the exploration and development of mineral properties, through our equity investee (see note 3), with a focus on the Upper Kobuk Mineral Projects (“UKMP”), including the Arctic and Bornite Projects located in Northwest Alaska in the United States of America (“US”). The Company also conducts early-stage exploration through a wholly owned subsidiary, 995 Exploration Inc.  

These interim consolidated financial statements have been prepared on a going concern basis which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.  At February 28, 2023, we had a working capital surplus of $1.0 million (2022 - $2.4 million) and an accumulated deficit of $71.9 million (2022 - $66.9 million). The Company has no recurring source of cash inflows at its current stage.  The Company’s cash outflow from operations was $0.9 million for the first quarter ended February 28, 2023.  The Company intends to finance its future requirements through a combination of debt and/or equity issuance.  There is no assurance that the Company will be able to obtain such financings or obtain them on favourable terms.  These uncertainties raise substantial doubt about the Company’s ability to continue as a going concern.  These interim consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.  Such adjustments could be material.

XML

Summary of significant accounting policies

3 Months Ended

Feb. 28, 2023

Summary of significant accounting policies

Summary of significant accounting policies

2)    Summary of significant accounting policies

Basis of presentation

These interim consolidated financial statements have been prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Trilogy and its wholly owned subsidiaries, NovaCopper US Inc. (dba “Trilogy Metals US”) and 995 Exploration Inc. All intercompany transactions are eliminated on consolidation. For variable interest entities (“VIEs”) where Trilogy is not the primary beneficiary, we use the equity method of accounting.

All figures are in United States dollars unless otherwise noted. References to CDN$ refer to amounts in Canadian dollars.

These interim consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s financial position as of February 28, 2023 and our results of operations and cash flows for the three-month period ended February 28, 2023 and February 28, 2022. The results of operations for the three-month period ended February 28, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending November 30, 2023.

As these interim consolidated financial statements do not contain all of the disclosures required by U.S. GAAP for annual financial statements, these interim consolidated financial statements should be read in conjunction with the annual financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2022, filed with the U.S. Securities and Exchange Commission (“SEC”) and Canadian securities regulatory authorities on February 14, 2023.

These interim consolidated financial statements were approved by the Company’s Audit Committee on behalf of the Board of Directors for issue on April 4, 2023.

Use of estimates and measurement uncertainties

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions of future events that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of expenditures during the period. Significant

judgments include the assessment of potential indicators of equity method investments where key judgement is the delay on the Ambler Access Project is temporary and the delay was considered when assessing indicators of impairment. Significant estimates include the measurement of income taxes, and the valuation of stock-based compensation. Actual results could differ materially from those reported.

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable. Significant judgments are made in assessing the possibility of impairment. Factors that may be indicative of an impairment include a loss in the value of an investment that is not temporary. Management considers several factors in considering if an indicator of impairment has occurred, including but not limited to, sustained losses by the investment, the absence of the ability to recover the carrying amount of the investment, significant changes in the legal, business or regulatory environment, significant adverse changes impacting the investee and internal reporting indicating the economic performance of an investment is, or will be, worse than expected. 

These factors are subjective and require consideration at each period end. If an indicator of impairment is determined to exist, the fair value of the impaired investment is determined based on the valuation of cohort companies with similar projects or upon the present value of expected future cash flows using discount rates and other assumptions believed to be consistent with those used by principal market participants and observed market earnings multiples of comparable companies. 

Management calculates the estimated undiscounted future net cash flows relating to the asset or asset group using estimated future prices, proven and probable reserves and other mineral resources, and operating, capital and reclamation costs. When the carrying value of an asset exceeds the related undiscounted cash flows, the asset is written down to its estimated fair value, which is usually determined using discounted future cash flows. Management’s estimates of mineral prices, mineral resources, foreign exchange rates, production levels operating, capital and reclamation costs are subject to risk and uncertainties that may affect the determination of the recoverability of the long-lived asset. It is possible that material changes could occur that may adversely affect management’s estimates.

XML

Investment in Ambler Metals LLC

3 Months Ended

Feb. 28, 2023

Investment in Ambler Metals LLC

Investment in Ambler Metals LLC

3)    Investment in Ambler Metals LLC

(a) Formation of Ambler Metals LLC

On February 11, 2020, the Company completed the formation of a 50/50 joint venture named Ambler Metals LLC (“Ambler Metals”) with South32 Limited (“South32”). As part of the formation of the joint venture, Trilogy contributed all its assets associated with the UKMP, including the Arctic and Bornite Projects, while South32 contributed cash of $145 million, resulting in each party’s subsidiaries directly owning a 50% interest in Ambler Metals.

Ambler Metals is an independently operated company jointly controlled by Trilogy and South32 through a four-member board, of which two members are appointed by Trilogy based on its 50% equity interest. All significant decisions related to the UKMP require the approval of both companies. We determined that Ambler Metals is a VIE because it is expected to need additional funding from its owners for its significant activities. However, we concluded that we are not the primary beneficiary of Ambler Metals as the power to direct its activities, through its board, is shared under the Ambler Metals LLC limited liability company agreement. As we have significant influence over Ambler Metals through our representation on its board, we use the equity method of accounting for our investment in Ambler Metals. Our investment in Ambler Metals was initially measured at its fair value of $176 million upon recognition. Our maximum exposure to loss in this entity is limited to the carrying amount of our investment in Ambler Metals, which, as at February 28, 2023, totaled $141.4 million.

(b) Carrying value of equity method investment

Trilogy recognized, based on its 50% ownership interest in Ambler Metals, an equity loss equivalent to its pro rata share of Ambler Metals’ comprehensive loss of $3.0 million for the three-month period ending February 28, 2023 (2022 - $3.8 million).  During the three-month period ending February 28, 2023, Trilogy made a $111,000 equity contribution to Ambler Metals through the issuance of 143,505 common shares of the Company as part of the long-term incentive compensation for Ambler Metals executives. Likewise, South32 made an equivalent equity contribution to Ambler Metals for $111,000 in cash for their 50% share. The carrying value of Trilogy’s 50% investment in Ambler Metals as at February 28, 2023 is summarized on the following table.

	in thousands of dollars
	$
November 30, 2022, Investment in Ambler Metals	142,754
Joint venture equity contribution	111
Share of loss on equity investment for the three month period ending February 28, 2023	(1,485)
February 28, 2023, Investment in Ambler Metals	141,380

(c) The following table summarizes Ambler Metals’ Balance Sheet as at February 28, 2023.

	in thousands of dollars
	February 28, 2023	November 30, 2022
	$	$
Total assets	109,541	114,049
Cash	76,476	80,755
Mineral properties	30,899	30,899
Total liabilities	(2,574)	(4,335)
Accounts payable and accrued liabilities	(1,962)	(3,664)
Members' equity (total assets less total liabilities)	106,967	109,714

Members’ cash is held at one bank, the majority of cash is uninsured as at February 28, 2023.

(d) The following table summarizes Ambler Metals' loss for the three-month period ending February 28, 2023.

	in thousands of dollars
		For the three months ended
		February 28, 2023	February 28, 2022
		$	$
Depreciation		37	23
Corporate salaries and wages		444	474
General and administrative		133	232
Mineral property expense		2,285	3,040
Professional fees		159	297
Foreign exchange (gain)/loss		—	2
Interest income		(89)	(248)
Comprehensive loss		2,969	3,820

XML

Accounts payable and accrued liabilities

3 Months Ended

Feb. 28, 2023

Accounts Payable and Accrued Liabilities [Abstract]

Accounts payable and accrued liabilities

4)    Accounts payable and accrued liabilities

		in thousands of dollars
	February 28, 2023	November 30, 2022
	$	$
Trade accounts payable	251	188
Accrued liabilities	146	36
Accrued salaries and vacation	273	121
Accounts payable and accrued liabilities	670	345

Included in accrued salaries and vacation approximately $155,000 was settled, subsequent to the end of the first quarter, on March 1, 2023 through the issuance of common shares of the Company.

XML

Leases

3 Months Ended

Feb. 28, 2023

Leases

Leases

5)    Leases

(a) Right-of-use asset

	in thousands of dollars
	$
Balance as at November 30, 2022	319
Net amortization	(43)
Balance as at February 28, 2023	276

(b) Lease liabilities

The Company’s lease arrangements primarily consist of an operating lease for our office space ending in June 2024. There are no extension options.

Total lease expense recorded within general and administrative expenses was comprised of the following components:

	in thousands of dollars
	Three months ended	Three months ended
	February 28, 2023	February 28, 2022
	$	$
Operating lease costs	47	47
Variable lease costs	36	35
Total lease expense	83	82

Variable lease costs consist primarily of the Company’s portion of operating costs associated with the office space lease as the Company elected to apply the practical expedient not to separate lease and non-lease components.

As of February 28, 2023, the weighted-average remaining lease term is 1.2 years and the weighted-average discount rate is 8%. Significant judgment was used in the determination of the incremental borrowing rate which included estimating the Company’s credit rating.

Supplemental cash and non-cash information relating to our leases during the three-month period ending February 28, 2023 are as follows:

● Cash paid for amounts included in the measurement of lease liabilities was $49,310.

Future minimum payments relating to the lease recognized in our balance sheet as of February 28, 2023 are as follows:

	in thousands of dollars
	February 28, 2023
Fiscal year	$
2023	149
2024	33
2025	—
Total undiscounted lease payments	182
Effect of discounting	(6)
Present value of lease payments recognized as lease liability	176

XML

Share capital

3 Months Ended

Feb. 28, 2023

Share capital.

Share capital

6)    Share capital

Authorized:

unlimited common shares, no par value

	in thousands of dollars, except share amounts
	Number of shares	Ascribed value
		$
November 30, 2022	146,225,035	182,178
Restricted Share Units	2,346,366	1,538
Services settled by common shares	7,793	4
Joint venture equity contribution (note 4(b))	143,505	111
February 28, 2023, issued and outstanding	148,722,699	183,831

On April 30, 2012, under the NovaGold Arrangement, Trilogy committed to issue common shares to satisfy holders of NovaGold deferred share units (“NovaGold DSUs”), once vested, on record as of the close of business April 27, 2012. When vested, Trilogy committed to deliver one common share to the holder for every six shares of NovaGold the holder is entitled to receive, rounded down to the nearest whole number. As of February 28, 2023, a total of 9,293 NovaGold DSUs remain outstanding representing a right to receive 1,549 Common Shares in Trilogy, which will settle upon certain directors retiring from NovaGold’s board.

(a) Stock options

During the three-month period ended February 28, 2023, the Company granted 3,230,000 stock options (2022 - 1,734,500 stock options) at an exercise price of CDN$0.78 (2022 - CDN$2.21) to employees, consultants and directors exercisable for a period of five years with various vesting terms from immediate vesting to vesting over a two-year period. The fair value attributable to options granted in the period was CDN$0.37 (2022 - CDN$0.90).

For the three-month period ended February 28, 2023, Trilogy recognized a stock-based compensation charge of $0.5 million (2022 - $0.86 million) for options granted to directors, employees and service providers, net of estimated forfeitures.

The fair value of the stock options recognized in the period has been estimated using the Black-Scholes option pricing model.

Assumptions used in the pricing model for the three-month period ended February 28, 2023 are as provided below.

	February 28, 2023
Risk-free interest rates	3.49%
Exercise price	CDN$0.78
Expected life	3 years
Expected volatility	67.7%
Expected dividends	Nil

As of February 28, 2023, there were 2,148,424 non-vested options outstanding with a weighted average exercise price of CDN$1.03; the non-vested stock option expense not yet recognized was $0.47 million. This expense is expected to be recognized over the 22 months.

A summary of the Company’s stock option plan and changes during the three-month period ended February 28, 2023 is as follows:

		February 28, 2023
		Weighted average
		exercise price
	Number of options	CDN$
Balance – beginning of the period	11,225,400	2.49
Granted	3,230,000	0.78
Expired	(870,000)	1.05
Balance – end of the period	13,585,400	2.18

There were no stock options exercised during the first quarter 2023.

The following table summarizes information about the stock options outstanding at February 28, 2023.

	Outstanding			Exercisable		Unvested
			Weighted		Weighted
	Number of	Weighted	average	Number of	average	Number of
	outstanding	average years	exercise price	exercisable	exercise price	unvested
Range of exercise price - CDN	options	to expiry	CDN$	options	CDN$	options
$0.75 to $1.00	3,230,000	4.77	0.78	1,463,328	0.78	1,766,672
$2.00 to $2.50	2,396,250	2.96	2.27	2,014,498	2.28	381,752
$2.51 to $3.00	6,411,650	2.14	2.64	6,411,650	2.64	—
$3.01 to $3.41	1,547,500	1.81	3.03	1,547,500	3.03	—
	13,585,400	2.87	2.18	11,436,976	2.39	2,148,424

The aggregate intrinsic value of vested stock options (the market value less the exercise price) at February 28, 2023 was $0.02 million (2022 - $0.15 million) and the aggregate intrinsic value of exercised options for the three-month period ending February 28, 2023 was $Nil million (2022 - $0.03 million).

(b) Restricted Share Units and Deferred Share Units

The Company has a Restricted Share Unit Plan (“RSU Plan”) to provide long-term incentives to employees and consultants and a Non-Executive Director Deferred Share Unit Plan (“DSU Plan”) to offset cash payments for fees to directors.  Awards under the RSU Plan and DSU Plan have been settled in common shares of the Company with each restricted share unit

(“RSU”) and deferred share unit (“DSU”) entitling the holder to receive one common share of the Company.  All units are accounted for as equity-settled awards.

A summary of the Company’s unit plans and changes during the three-month period ending February 28, 2023 is as follows:

	Number of RSUs	Number of DSUs
Balance – beginning of the period	257,268	1,560,734
Granted	3,699,297	760,519
Vested	(2,345,927)	—
Balance – end of the period	1,610,638	2,321,253

For the three-month period ending February 28, 2023, Trilogy recognized a combined RSU and DSU stock-based compensation charge of $1.1 million (2022 - $1.0 million), net of estimated forfeitures.

XML

Financial instruments

3 Months Ended

Feb. 28, 2023

Financial instruments

Financial instruments

7)    Financial instruments

The Company is exposed to a variety of risks arising from financial instruments. These risks and management’s objectives, policies and procedures for managing these risks are disclosed as follows.

The Company’s financial instruments consist of cash, accounts receivable, deposits, and accounts payable and accrued liabilities. The fair value of the Company’s financial instruments approximates their carrying value due to the short-term nature of their maturity. The Company’s financial instruments initially measured at fair value and then held at amortized cost include cash, accounts receivable, deposits, and accounts payable and accrued liabilities.

Financial risk management

The Company’s activities expose it to certain financial risks, including currency risk, credit risk, liquidity risk, interest risk and price risk.

(a) Currency risk

Currency risk is the risk of a fluctuation in financial asset and liability settlement amounts due to a change in foreign exchange rates. The Company operates in the United States and Canada. The Company’s exposure to currency risk at February 28, 2023 is limited to the Canadian dollar balances consisting of cash of approximately CDN$71,000, accounts receivable of approximately CDN$35,000 and accounts payable of approximately CDN$320,000. Based on a 10% change in the US-Canadian exchange rate, assuming all other variables remain constant, the Company’s net loss would change by approximately $35,000.

(b) Credit risk

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company holds cash with a Canadian chartered financial institution of which the majority is uninsured as at February 28, 2023. The Company’s only significant exposure to credit risk is equal to the balance of cash as recorded in the financial statements.

(c) Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulties raising funds to meet its financial obligations as they fall due. The Company is in the exploration stage and does not have cash inflows from operations; therefore, the Company manages liquidity risk through the management of its capital structure and financial leverage.

Contractually obligated undiscounted cash flow requirements as at February 28, 2023 are as follows:

	in thousands of dollars
	Total	< 1 Year	1–2 Years	2–5 Years	Thereafter
	$	$	$	$	$
Accounts payable and accrued liabilities	670	670	—	—	—
Office lease	182	182	—	—	—
	852	852	—	—	—

Included in accounts payable and accrued liabilities approximately $155,000 is for accrued salaries that were settled, subsequent to the end of the first quarter, on March 1, 2023 through the issuance of common shares of the Company (note 9).

(d) Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk with respect to interest earned on cash. Based on balances as at February 28, 2023, a 1% change in interest rates would result in a negligible change in net loss, assuming all other variables remain constant.

As we are currently in the exploration phase none of our financial instruments are exposed to commodity price risk; however, our ability to obtain long-term financing and its economic viability could be affected by commodity price volatility.

XML

Commitment

3 Months Ended

Feb. 28, 2023

Commitment

Commitment

8)    Commitment

The Company has commitments with respect to an office lease requiring future minimum lease payments as summarized in note 5(b) above.

XML

Subsequent events

3 Months Ended

Feb. 28, 2023

Subsequent Events [Abstract]

Subsequent events

9) Subsequent event

On March 1, 2023 the Board of Directors and senior management were granted 213,463 RSUs and 162,469 DSUs in settlement of approximately $247,000 of director fees and accrued salaries, all vesting immediately. The grants were in support of an effort to preserve cash and increase share ownership by settling director fees and a portion of senior management salaries in shares of the Company.

XML

Summary of significant accounting policies (Policies)

3 Months Ended

Feb. 28, 2023

Summary of significant accounting policies

Basis of presentation

Basis of presentation

These interim consolidated financial statements have been prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Trilogy and its wholly owned subsidiaries, NovaCopper US Inc. (dba “Trilogy Metals US”) and 995 Exploration Inc. All intercompany transactions are eliminated on consolidation. For variable interest entities (“VIEs”) where Trilogy is not the primary beneficiary, we use the equity method of accounting.

All figures are in United States dollars unless otherwise noted. References to CDN$ refer to amounts in Canadian dollars.

These interim consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s financial position as of February 28, 2023 and our results of operations and cash flows for the three-month period ended February 28, 2023 and February 28, 2022. The results of operations for the three-month period ended February 28, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending November 30, 2023.

As these interim consolidated financial statements do not contain all of the disclosures required by U.S. GAAP for annual financial statements, these interim consolidated financial statements should be read in conjunction with the annual financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2022, filed with the U.S. Securities and Exchange Commission (“SEC”) and Canadian securities regulatory authorities on February 14, 2023.

These interim consolidated financial statements were approved by the Company’s Audit Committee on behalf of the Board of Directors for issue on April 4, 2023.

Use of estimates and measurement uncertainties

Use of estimates and measurement uncertainties

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions of future events that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of expenditures during the period. Significant

judgments include the assessment of potential indicators of equity method investments where key judgement is the delay on the Ambler Access Project is temporary and the delay was considered when assessing indicators of impairment. Significant estimates include the measurement of income taxes, and the valuation of stock-based compensation. Actual results could differ materially from those reported.

Management assesses the possibility of impairment in the carrying value of its equity method investment in Ambler Metals whenever events or circumstances indicate that the carrying amount of the investment may not be recoverable. Significant judgments are made in assessing the possibility of impairment. Factors that may be indicative of an impairment include a loss in the value of an investment that is not temporary. Management considers several factors in considering if an indicator of impairment has occurred, including but not limited to, sustained losses by the investment, the absence of the ability to recover the carrying amount of the investment, significant changes in the legal, business or regulatory environment, significant adverse changes impacting the investee and internal reporting indicating the economic performance of an investment is, or will be, worse than expected. 

These factors are subjective and require consideration at each period end. If an indicator of impairment is determined to exist, the fair value of the impaired investment is determined based on the valuation of cohort companies with similar projects or upon the present value of expected future cash flows using discount rates and other assumptions believed to be consistent with those used by principal market participants and observed market earnings multiples of comparable companies. 

Management calculates the estimated undiscounted future net cash flows relating to the asset or asset group using estimated future prices, proven and probable reserves and other mineral resources, and operating, capital and reclamation costs. When the carrying value of an asset exceeds the related undiscounted cash flows, the asset is written down to its estimated fair value, which is usually determined using discounted future cash flows. Management’s estimates of mineral prices, mineral resources, foreign exchange rates, production levels operating, capital and reclamation costs are subject to risk and uncertainties that may affect the determination of the recoverability of the long-lived asset. It is possible that material changes could occur that may adversely affect management’s estimates.

XML

Investment in Ambler Metals LLC (Tables)

3 Months Ended

Feb. 28, 2023

Investment in Ambler Metals LLC

Schedule of equity investment

	in thousands of dollars
	$
November 30, 2022, Investment in Ambler Metals	142,754
Joint venture equity contribution	111
Share of loss on equity investment for the three month period ending February 28, 2023	(1,485)
February 28, 2023, Investment in Ambler Metals	141,380

Schedule of Ambler Metals LLC's Balance Sheet

	in thousands of dollars
	February 28, 2023	November 30, 2022
	$	$
Total assets	109,541	114,049
Cash	76,476	80,755
Mineral properties	30,899	30,899
Total liabilities	(2,574)	(4,335)
Accounts payable and accrued liabilities	(1,962)	(3,664)
Members' equity (total assets less total liabilities)	106,967	109,714

Schedule of Ambler Metals LLC's net loss

	in thousands of dollars
		For the three months ended
		February 28, 2023	February 28, 2022
		$	$
Depreciation		37	23
Corporate salaries and wages		444	474
General and administrative		133	232
Mineral property expense		2,285	3,040
Professional fees		159	297
Foreign exchange (gain)/loss		—	2
Interest income		(89)	(248)
Comprehensive loss		2,969	3,820

XML

Accounts payable and accrued liabilities (Tables)

3 Months Ended

Feb. 28, 2023

Accounts Payable and Accrued Liabilities [Abstract]

Schedule of accounts payable and accrued liabilities

		in thousands of dollars
	February 28, 2023	November 30, 2022
	$	$
Trade accounts payable	251	188
Accrued liabilities	146	36
Accrued salaries and vacation	273	121
Accounts payable and accrued liabilities	670	345

XML

Leases (Tables)

3 Months Ended

Feb. 28, 2023

Leases

Schedule of right-of-use asset

	in thousands of dollars
	$
Balance as at November 30, 2022	319
Net amortization	(43)
Balance as at February 28, 2023	276

Schedule of lease expenses

	in thousands of dollars
	Three months ended	Three months ended
	February 28, 2023	February 28, 2022
	$	$
Operating lease costs	47	47
Variable lease costs	36	35
Total lease expense	83	82

Schedule of future minimum payments

	in thousands of dollars
	February 28, 2023
Fiscal year	$
2023	149
2024	33
2025	—
Total undiscounted lease payments	182
Effect of discounting	(6)
Present value of lease payments recognized as lease liability	176

XML

Share capital (Tables)

3 Months Ended

Feb. 28, 2023

Share capital.

Schedule of common stock outstanding roll forward

	in thousands of dollars, except share amounts
	Number of shares	Ascribed value
		$
November 30, 2022	146,225,035	182,178
Restricted Share Units	2,346,366	1,538
Services settled by common shares	7,793	4
Joint venture equity contribution (note 4(b))	143,505	111
February 28, 2023, issued and outstanding	148,722,699	183,831

Schedule of assumptions used in the pricing model

	February 28, 2023
Risk-free interest rates	3.49%
Exercise price	CDN$0.78
Expected life	3 years
Expected volatility	67.7%
Expected dividends	Nil

Summary of the company's stock option plan

		February 28, 2023
		Weighted average
		exercise price
	Number of options	CDN$
Balance – beginning of the period	11,225,400	2.49
Granted	3,230,000	0.78
Expired	(870,000)	1.05
Balance – end of the period	13,585,400	2.18

Summary of information about stock options

	Outstanding			Exercisable		Unvested
			Weighted		Weighted
	Number of	Weighted	average	Number of	average	Number of
	outstanding	average years	exercise price	exercisable	exercise price	unvested
Range of exercise price - CDN	options	to expiry	CDN$	options	CDN$	options
$0.75 to $1.00	3,230,000	4.77	0.78	1,463,328	0.78	1,766,672
$2.00 to $2.50	2,396,250	2.96	2.27	2,014,498	2.28	381,752
$2.51 to $3.00	6,411,650	2.14	2.64	6,411,650	2.64	—
$3.01 to $3.41	1,547,500	1.81	3.03	1,547,500	3.03	—
	13,585,400	2.87	2.18	11,436,976	2.39	2,148,424

Schedule of restricted share Units and deferred share units plans

	Number of RSUs	Number of DSUs
Balance – beginning of the period	257,268	1,560,734
Granted	3,699,297	760,519
Vested	(2,345,927)	—
Balance – end of the period	1,610,638	2,321,253

XML

Financial instruments (Tables)

3 Months Ended

Feb. 28, 2023

Financial instruments

Schedule of contractually obligated cash flow requirements

	in thousands of dollars
	Total	< 1 Year	1–2 Years	2–5 Years	Thereafter
	$	$	$	$	$
Accounts payable and accrued liabilities	670	670	—	—	—
Office lease	182	182	—	—	—
	852	852	—	—	—

XML

Nature of operations and Going Concern (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 28, 2023	Feb. 28, 2022	Nov. 30, 2022
Nature of operations and Going Concern
Working Capital	$ 1,000	$ 2,400
Accumulated deficit	(71,934)	(66,900)	$ (66,862)
Cash flow from operation	$ (885)	$ (1,480)

XML

Summary of significant accounting policies - Investment in affiliates and Mineral properties, development costs (Details) - Ambler Metals LLC	Feb. 28, 2023	Feb. 11, 2020
Schedule of Equity Method Investments [Line Items]
Percentage of ownership	50.00%	50.00%
South32
Schedule of Equity Method Investments [Line Items]
Percentage of ownership	50.00%	50.00%

XML

Investment in Ambler Metals LLC - Narrative (Details)		3 Months Ended
	Feb. 11, 2020 USD ($) Owner	Feb. 28, 2023 USD ($) shares	Feb. 28, 2022 USD ($)	Nov. 30, 2022 USD ($)
Schedule of Equity Method Investments [Line Items]
Joint venture, contributed amount		$ 111,000
Comprehensive (loss) earnings for the year		(5,072,000)	$ (5,023,000)
Ambler Metals LLC
Schedule of Equity Method Investments [Line Items]
Joint venture, contributed amount		111,000
Contribution made to joint venture		$ 111,000
Joint venture contribution made in common shares | shares		143,505
Percentage of ownership	50.00%	50.00%
Comprehensive (loss) earnings for the year		$ (3,000,000.0)	$ (3,800,000)
Number of board members | Owner	4
Number of members appointed by Trilogy | Owner	2
Maximum exposure to loss		141,400,000
Fair value ascribed to Ambler Metals LLC interest				$ 142,754,000
South32 | Ambler Metals LLC
Schedule of Equity Method Investments [Line Items]
Contribution made to joint venture		$ 111,000
Percentage of ownership	50.00%	50.00%
South32
Schedule of Equity Method Investments [Line Items]
Contribution made to joint venture	$ 145,000,000

XML

Investment in Ambler Metals LLC - Financial information (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 28, 2023	Feb. 28, 2022	Nov. 30, 2022	Feb. 11, 2020
The carrying value of equity method investment
Joint venture, contributed amount	$ 111
Share of loss on equity investment	(1,485)	$ (1,910)
Investment in Ambler Metals	141,380		$ 142,754
Assets [Abstract]
Total assets	143,537		145,995
Cash	1,682		2,573
Liabilities [Abstract]
Total liabilities	(846)		(567)
Ambler Metals' Net Loss
General and administrative	408	397
Professional Fees	570	245
Foreign exchange (gain)/loss	(4)	3
Ambler Metals
Assets [Abstract]
Total assets	109,541		114,049
Cash	76,476		80,755
Mineral properties	30,899		30,899
Liabilities [Abstract]
Total liabilities	(2,574)		(4,335)
Accounts payable and accrued liabilities	(1,962)		(3,664)
Members' equity (total assets less total liabilities)	106,967		109,714
Ambler Metals' Net Loss
Depreciation	37	23
Corporate salaries and wages	444	474
General and administrative	133	232
Mineral property expense	2,285	3,040
Professional Fees	159	297
Foreign exchange (gain)/loss		2
Interest income	(89)	(248)
Comprehensive loss	2,969	$ 3,820
Ambler Metals LLC
The carrying value of equity method investment
Investment in Ambler Metals			$ 142,754
Joint venture, contributed amount	111
Share of loss on equity investment	(1,485)
Investment in Ambler Metals	$ 141,380			$ 176,000

XML

Accounts payable and accrued liabilities (Details) - USD ($)	Mar. 01, 2023	Feb. 28, 2023	Nov. 30, 2022
Subsequent Event [Line Items]
Trade accounts payable		$ 251,000	$ 188,000
Accrued liabilities		146,000	36,000
Accrued salaries and vacation		273,000	121,000
Accounts payable and accrued liabilities		$ 670,000	$ 345,000
Subsequent Event
Subsequent Event [Line Items]
Accrued salaries and vacation	$ 155,000

XML

Leases - Narrative (Details)	3 Months Ended
	Feb. 28, 2023 USD ($)
Leases
Lessee, Operating Lease, Existence of Option to Extend [true false]	false
Weighted-average remaining lease term	1 year 2 months 12 days
Weighted-average discount rate	8.00%
Cash paid for amounts included in the measurement of lease liabilities	$ 49,310

XML

Leases - Right of use asset (Details) $ in Thousands	3 Months Ended
	Feb. 28, 2023 USD ($)
Leases
Balance, beginning	$ 319
Net amortization	(43)
Balance, ending	$ 276

XML

Leases - Lease liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Leases
Operating lease costs	$ 47	$ 47
Variable lease costs	36	35
Total lease expense	$ 83	$ 82

XML

Leases - Future minimum payments (Details) $ in Thousands	Feb. 28, 2023 USD ($)
Future minimum payments
2023	$ 149
2024	33
Total undiscounted lease payments	182
Effect of discounting	(6)
Present value of lease payments recognized as lease liability	$ 176

XML

Share capital - Narrative (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Feb. 28, 2023 USD ($) $ / shares shares	Feb. 28, 2023 USD ($) $ / shares $ / shares shares	Feb. 28, 2022 USD ($) $ / shares shares	Feb. 28, 2022 USD ($) $ / shares	Feb. 28, 2023 $ / shares	Nov. 30, 2022 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, conversion	1
Stock-based compensation | $	$ (2,220)		$ (1,865)
Non-vested stock options outstanding	13,585,400	13,585,400
Weighted average exercise price options outstanding | $ / shares	$ 2.18	$ 2.18
Period for recognition of stock compensation expense	22 months
Proceeds from exercise of options | $			18
Aggregate intrinsic value, vested options | $	$ 20	$ 20	150	$ 150
Aggregate intrinsic value, options exercised | $			$ 30
Share capital
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock committed for issuance	148,722,699	148,722,699				146,225,035
Exercise of options, Number of shares			31,674
Nonvested Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-vested stock options outstanding	2,148,424	2,148,424
Weighted average exercise price options outstanding | $ / shares					$ 1.03
Stock option expense not yet recognized | $	$ 470	$ 470
DSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation | $	$ 1,100		$ 1,000
Granted units	760,519
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted units	3,699,297
Stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-vested stock options outstanding	13,585,400	13,585,400				11,225,400
Weighted average exercise price options outstanding | $ / shares	$ 2.18	$ 2.18				$ 2.49
Exercise of options, Number of shares	0
Stock options granted	3,230,000
Weighted-average exercise price | $ / shares	$ 0.78
Employees, consultants and directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted, expiration period	5 years
Stock options granted	3,230,000		1,734,500
Vesting period	2 years
Weighted-average exercise price | $ / shares		$ 0.78		$ 2.21
Stock options granted, weighted average fair value | $ / shares	$ 0.37		$ 0.90
Directors, employees and service providers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation | $	$ 500		$ 860
Directors, employees and service providers | NovaGold Arrangement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, conversion	6
Directors, employees and service providers | NovaGold Arrangement | Nonvested Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock committed for issuance	1,549	1,549
Non-vested stock options outstanding	9,293	9,293

XML

Share capital - Authorized unlimited common shares, no par value (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Feb. 28, 2023	Feb. 28, 2022	Nov. 30, 2022
Class of Stock [Line Items]
Unlimited common shares authorized	Unlimited		Unlimited
Common Stock, No Par Value	$ 0		$ 0
Beginning Balance	$ 145,428	$ 166,039	$ 166,039
Beginning balance, Number of shares issued	146,225,035
Services settled by common shares, Ascribed value	$ 4
Joint venture equity contribution (note 4(b)), Ascribed value	111
Ending Balance	$ 142,691	162,950	$ 145,428
Ending balance, Number of shares issued	148,722,699		146,225,035
Share capital
Class of Stock [Line Items]
Beginning balance, Number of shares	146,225,035
Beginning Balance	$ 182,178	$ 180,820	$ 180,820
Beginning balance, Ascribed value	$ 182,178
Exercise of options, Number of shares		31,674
Restricted share units, Number of shares	2,346,366	391,332
Restricted share units, Ascribed value	$ 1,538
Services settled by common shares, Number of shares	7,793
Services settled by common shares, Ascribed value	$ 4
Joint venture equity contribution (note 4(b)), Number of shares	143,505	31,469
Joint venture equity contribution (note 4(b)), Ascribed value	$ 111
Ending balance, Number of shares outstanding	148,722,699		146,225,035
Ending balance, Ascribed value	$ 183,831		$ 182,178
Ending Balance	$ 183,831	$ 181,571	$ 182,178

XML

Share capital - Assumptions used in the pricing model (Details)	3 Months Ended
	Feb. 28, 2023 $ / shares
Share capital.
Risk-free interest rates	3.49%
Exercise price	$ 0.78
Expected life	3 years
Expected volatility	67.70%
Expected dividends

XML

Share capital - Stock options plans and changes (Details)	3 Months Ended
	Feb. 28, 2023 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance - end of period, number of options	13,585,400
Balance - end of period, weighted average exercise price | $ / shares	$ 2.18
Stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance - beginning of the year, number of options	11,225,400
Balance - beginning of the year, weighted average exercise price | $ / shares	$ 2.49
Number of options, Granted	3,230,000
Weighted average exercise price, Granted | $ / shares	$ 0.78
Number of options, Exercised	0
Number of options, Cancelled	(870,000)
Weighted average exercise price, Cancelled | $ / shares	$ 1.05
Balance - end of period, number of options	13,585,400
Balance - end of period, weighted average exercise price | $ / shares	$ 2.18

XML

Share capital - Stock options outstanding (Details)	3 Months Ended
	Feb. 28, 2023 $ / shares shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of outstanding options | shares	13,585,400
Weighted average years to expiry	2 years 10 months 13 days
Weighted average exercise price options outstanding	$ 2.18
Number of exercisable options | shares	11,436,976
Weighted average exercise price exercisable	$ 2.39
Number of unvested options | shares	2,148,424
$0.75 to $1.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price lower range limit	$ 0.75
Exercise price upper range limit	$ 1.00
Number of outstanding options | shares	3,230,000
Weighted average years to expiry	4 years 9 months 7 days
Weighted average exercise price options outstanding	$ 0.78
Number of exercisable options | shares	1,463,328
Weighted average exercise price exercisable	$ 0.78
Number of unvested options | shares	1,766,672
$2.01 to $2.50
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price lower range limit	$ 2.00
Exercise price upper range limit	$ 2.50
Number of outstanding options | shares	2,396,250
Weighted average years to expiry	2 years 11 months 15 days
Weighted average exercise price options outstanding	$ 2.27
Number of exercisable options | shares	2,014,498
Weighted average exercise price exercisable	$ 2.28
Number of unvested options | shares	381,752
$2.51 to $3.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price lower range limit	$ 2.51
Exercise price upper range limit	$ 3.00
Number of outstanding options | shares	6,411,650
Weighted average years to expiry	2 years 1 month 20 days
Weighted average exercise price options outstanding	$ 2.64
Number of exercisable options | shares	6,411,650
Weighted average exercise price exercisable	$ 2.64
Number of unvested options | shares	0
$3.01 to $3.41
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of outstanding options | shares	1,547,500
Weighted average years to expiry	1 year 9 months 21 days
Weighted average exercise price options outstanding	$ 3.03
Number of exercisable options | shares	1,547,500
Weighted average exercise price exercisable	$ 3.03
Number of unvested options | shares	0

XML

Share capital - Unit plans and changes (Details)	3 Months Ended
	Feb. 28, 2023 shares
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance - beginning of the year	257,268
Granted	3,699,297
Vested	(2,345,927)
Balance - end of period	1,610,638
DSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance - beginning of the year	1,560,734
Granted	760,519
Balance - end of period	2,321,253

XML

Financial instruments - Narrative (Details)	3 Months Ended
	Feb. 28, 2023 USD ($)	Mar. 01, 2023 USD ($)	Feb. 28, 2023 CAD ($)	Nov. 30, 2022 USD ($)
Cash	$ 1,682,000			$ 2,573,000
Accounts receivable	$ 26,000			$ 17,000
Subsequent Event
Accrued salaries		$ 155,000
10% change in the US-Canadian exchange rate
Cash			$ 71,000
Accounts receivable			35,000
Accounts payable			$ 320,000
Change in foreign exchange rate	10.00%		10.00%
Foreign exchange loss	$ 35,000
1% change in interest rates
Change in interest rate	1.00%		1.00%

XML

Financial instruments - Contractually obligated cash flow requirements (Details) $ in Thousands	Feb. 28, 2023 USD ($)
Total	$ 852
Less than 1 year	852
Less than 1 Year	0
2 - 5 Years	0
Thereafter	0
Accounts payable and accrued liabilities
Total	670
Less than 1 year	670
Less than 1 Year	0
2 - 5 Years	0
Thereafter	0
Office lease
Total	182
Less than 1 year	182
Less than 1 Year	0
2 - 5 Years	0
Thereafter	$ 0

XML

Subsequent event (Details) - USD ($)		3 Months Ended
	Mar. 01, 2023	Feb. 28, 2023
RSUs
Subsequent Event [Line Items]
Granted		3,699,297
Subsequent Event
Subsequent Event [Line Items]
Accrued salaries and director fees	$ 247,000
Subsequent Event | RSUs | Director
Subsequent Event [Line Items]
Granted (in shares)	213,463
Subsequent Event | DSUs. | Employee
Subsequent Event [Line Items]
Granted (in shares)	162,469